Hippocampal neuronal loss and cognitive decline in LATE‐NC and ADNC among community‐dwelling older persons
Alzheimer s & Dementia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
Abstract
INTRODUCTION
This
study
investigates
the
inter‐related
roles
of
hippocampal
neuronal
loss
(HNL),
limbic‐predominant
age‐related
TAR‐DNA
binding
protein
43
kDa
(TDP‐43)
encephalopathy
neuropathologic
changes
(LATE‐NC),
and
Alzheimer's
disease
(ADNC)
on
cognitive
decline.
METHODS
Participants
underwent
annual
testing
autopsy.
HNL,
ADNC,
LATE‐NC,
other
pathologies
were
evaluated.
Regression
mixed‐effects
models
examined
association
HNL
with
ADNC
separately
Path
analyses
extent
to
which
associations
LATE‐NC
decline
attributable
HNL.
RESULTS
was
associated
more
severe
but
only
after
excluding
subjects
sclerosis
(HS).
faster
in
global
cognition
episodic,
semantic,
working
memory.
In
path
analyses,
about
61%
whereas
for
it
mostly
independent
DISCUSSION
has
an
contribution
acts
as
a
major
step
LATE‐NC‐related
Highlights
Hippocampal
(HNL)
is
prominent
feature
TDP‐43
(LATE‐NC)
less
so
(ADNC).
pathway
LATE‐NC.
Differential
mechanisms
degeneration
are
versus
ADNC.
Language: Английский
Association between hippocampal microglia, AD and LATE‐NC, and cognitive decline in older adults
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(5), P. 3193 - 3202
Published: March 17, 2024
This
study
investigates
the
relationship
between
microglia
inflammation
in
hippocampus,
brain
pathologies,
and
cognitive
decline.
Language: Английский
Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases
Lei‐Lei Jiang,
No information about this author
Xiangle Zhang,
No information about this author
Hongyu Hu
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12380 - 12380
Published: Nov. 18, 2024
Pathological
aggregation
of
a
specific
protein
into
insoluble
aggregates
is
common
hallmark
various
neurodegenerative
diseases
(NDDs).
In
the
earlier
literature,
each
NDD
characterized
by
one
or
two
pathogenic
proteins,
which
can
serve
as
disease-specific
biomarkers.
The
these
proteins
thought
to
be
major
cause
deleterious
result
in
most
NDDs.
However,
accumulating
evidence
shows
that
interact
and
co-aggregate
with
other
different
NDDs,
thereby
contributing
disease
onset
progression
synergistically.
During
past
years,
more
than
type
has
been
found
co-exist
some
individuals,
may
increase
complexity
pathogenicity
diseases.
This
article
reviews
discusses
biochemical
characteristics
molecular
mechanisms
underlying
co-aggregation
co-pathologies
associated
TDP-43
pathology.
aggregates,
amyotrophic
lateral
sclerosis
(ALS)
frontotemporal
lobar
degeneration
(FTLD),
often
detected
such
Alzheimer's
(AD),
Parkinson's
(PD),
Huntington's
(HD)
spinocerebellar
ataxia
2
(SCA2).
many
cases,
shown
multiple
vitro
vivo.
Furthermore,
co-occurrence
have
important
consequences
aggravate
Thus,
current
viewpoint
NDDs
their
relevance
gain
insights
patho-mechanisms
therapeutic
potential
Language: Английский